UCSF

ZINC03812913

Substance Information

In ZINC since Heavy atoms Benign functionality
September 27th, 2005 27 Yes

Other Names:

(+-)-Methyl (1R,2R,3R)-3-hydroxy-2-((E)-(4RS)-4-hydroxy-4-methyl-1-octenyl)-5-oxocyclopentaneheptanoate; (11-alpha,13E)-(+-)-11,16-Dihydroxy-16-methyl-9-oxoprost-13-en-1-oic acid methyl ester; ARTHROTEC; BRN 4155643; C22H38O5; CCRIS 6859; CYTOTEC; HSDB 35

(+/-)-15-Deoxy-(16RS)-16-hydroxy-16-methylprostaglandin E1 methyl ester

(11-alpha,13E)-(+-)-11,16-Dihydroxy-16-methyl-9-oxoprost-13-en-1-oic acid methyl ester

(11R,16S)-misoprostol

(16S)-15-deoxy--16-hydroxy-16-methyl-PGE1 methyl ester; methyl 11R,16S-dihydroxy-16-methyl-9-oxoprost-13E-en-1-oate

prost-

11.beta.-Misoprostol

59122-46-2

59122-46-2; Cytotec (TN); D00419; Misoprostol (JAN/USAN/INN)

62015-39-8

AC1NQZZA

Ambap103601-27-0

Arthrotec

ARTHROTEC; C22H38O5.C14H10Cl2NO2.Na; DICLOFENAC SODIUM; MISOPROSTOL; LS-178476

BAN

BRN 4155643

CCRIS 6859

CHEMBL606

CID5282381

Cytotec

Cytotec (TN)

D00419

DAP000358

DB00929

FDA

GyMiso

HMS2090L10

HSDB 3573

I14-11712

INN

Isprelor

JAN

M6807_SIGMA

Methyl (+-)-11-alpha,16-dihydroxy-16-methyl-9-oxoprost-13-en-1-oate

Methyl (11alpha,13E)-11,16-dihydroxy-16-methyl-9-oxoprost-13-en-1-oate

methyl (13E)-11,16-dihydroxy-16-methyl-9-oxoprost-13-en-1-oate

methyl 7-[(1R,2R,3R)-3-hydroxy-2-[(E)-4-hydroxy-4-methyloct-1-enyl]-5-oxocyclopentyl]heptanoate

methyl 7-{3-hydroxy-2-[(1E)-4-hydroxy-4-methyloct-1-en-1-yl]-5-oxocyclopentyl}heptanoate

Misodel

Misopess

Misoprostol (BAN

Misoprostol (FDA

Misoprostol (JAN/USAN/INN)

Misoprostolum

Misoprostolum [INN-Latin]

Misotol

MLS000028863

MolPort-003-666-830

NCGC00162445-01

NCGC00162445-02

Prost-13-en-1-oic acid, 11,16-dihydroxy-16-methyl-9-oxo-, methyl ester, (11alpha,13E)-

Prost-13-en-1-oic acid, 11,16-dihydroxy-16-methyl-9-oxo-, methyl ester, (11alpha,13E)-(+-)-

SC 29333

SC-29333

SC-30249

SMP1_000193

SMR000058558

UNII-0E43V0BB57

USAN)

XP-16J

Download: MOL2 SDF SMILES Flexibase

Physical Representations

Type pH range xlogP Des A‑Pol Apolar desolvation (kcal/mol) Des Pol Polar desolvation (kcal/mol) H Don H-bond donors H Acc H-bond acceptors Chg Net charge tPSA (Ų) MWT Molecular weight (g/mol) RB Rotatable bonds DL
Ref Reference (pH 7) 3.88 8.22 -10.5 2 5 0 84 382.541 14

Vendor Notes

Note Type Comments Provided By
ALOGPS_SOLUBILITY 1.64e-02 g/l DrugBank-approved
PUBCHEM_PATENT_ID EP0129908A1; EP0186181A2; EP0218953A2; EP0225044A1; EP0225044B1; EP0272918A2; EP0272918B1; EP0272987A2; EP0272987B1; EP0289512A1; EP0289512B1; EP0294757A2; EP0294757B1; EP0297842A2; EP0305756A1; EP0305756B1; EP0316168A1; EP0316168B1; EP0317959A2; EP031957 IBM Patent Data

Activity (Go SEA)

Analogs ( Draw Identity 99% 90% 80% 70% )